Results 151 to 160 of about 1,764,849 (239)

Ponto de vista Point of View

open access: yesArquivos Brasileiros de Cardiologia, 2007
Adib D. Jatene
doaj   +1 more source

Active Breaks in Primary and Secondary School Children and Adolescents: The Point of View of Teachers. [PDF]

open access: yesHealthcare (Basel)
Persiani M   +8 more
europepmc   +1 more source

Longitudinal genome‐wide aneuploidy measurements in circulating cell‐free DNA to predict lack of benefit from pembrolizumab in patients with metastatic urothelial cancer

open access: yesMolecular Oncology, EarlyView.
Many patients with urothelial cancer do not benefit from treatment with pembrolizumab, while at risk of severe side effects. Changes in the levels of circulating tumor DNA early during treatment, measured by a simple and affordable assay that can be easily implemented in the clinic, can be used as a prognostic tool to identify these patients.
Youssra Salhi   +14 more
wiley   +1 more source

Bowel Preparation for Colonoscopy: The Patient Point of View.

open access: yesDig Dis
Tontini G   +5 more
europepmc   +1 more source

MITF maintains genome stability in nonmelanocyte lineages

open access: yesMolecular Oncology, EarlyView.
MITF is essential for melanocyte survival and acts as an oncogene in 10%–20% of melanomas. We show that MITF depletion causes genome instability in nonmelanocytic cells, leading to LATS2‐mediated P53 activation, cell cycle arrest, and apoptosis. This study highlights the role of MITF as a genome maintenance factor beyond the melanocyte lineage. Created
Drifa H. Gudmundsdottir   +13 more
wiley   +1 more source

A novel quinazolinone insulin receptor inhibitor and its synergy with an EGFR inhibitor in glucose‐driven glioblastoma

open access: yesMolecular Oncology, EarlyView.
The novel styrylquinazolinone‐based molecule W1B effectively suppresses glioblastoma by inhibiting IGF1R and EGFR. In high‐glucose microenvironments driving tumor resistance, W1B acts synergistically with the EGFR inhibitor dacomitinib. This combination safely blocks compensatory survival signaling in zebrafish xenograft models. Showcasing promising in
Patryk Rurka   +9 more
wiley   +1 more source

Munchausen Syndrome: Another Point of View

open access: yesPediatrics and Neonatology, 2014
Tzee-Chung Wu
doaj   +1 more source

Hypersensitivity Reactions to Gadolinium-Based Contrast Agents: Update From an Allergist's Point of View. [PDF]

open access: yesClin Transl Allergy
Losa F   +14 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy